This essential review includes more than simply knowing how to select accurate diagnosis codes and correct OASIS responses. A coding and OASIS reviewer must also know:
what’s required for compliant face-to-face encounter documentation,
how to check that planned interventions support the primary need for skilled care and the primary and secondary diagnoses, and
how the data reported in OASIS matches up to documentation elsewhere in the record.
Poor documentation can undermine all the work home health agencies do to provide care for patients. Compliant documentation demonstrates eligibility, identifies the skilled care that patients require, and ensures ethical reimbursement.
Attendees will have the opportunity to take a 50-question post-test upon the conclusion of the event and receive a certificate of competency.
Or, contact a Customer Service representative at 855-225-5341.
DecisionHealth, an HCPro brand, is the industry’s leading source for home health agencies and medical practice facilities to receive the latest news, analysis, and regulatory guidance on Medicare coding and reimbursement, benchmarks, payments, and Health Insurance Portability and Accountability Act (HIPAA) compliance through its flagship publications, as well as a wide selection of coding books, educational events, and online tools. Visit http://www.decisionhealth.com/
For over 34 years, HCPro, a division of Simplify Compliance LLC, has specialized in providing the latest healthcare regulatory information through industry-leading publications, continuing education, online coding platforms, instructor-led training, events, consulting services, and more to deliver consistent training, achieve compliance, and maximize workflow efficiencies, resulting in measurable performance and financial improvements. Visit http://www.hcpro.com/.
This new methylcellulose is suitable for large-scale, high-speed manufacturing of alternative protein applications. Methylcellulose is also an effective binder and stabilizer for hybrid and meat products. The featured speakers will highlight how methylcellulose — which is also vegan, non-GMO and allergen-free — can be used in the economical formulation of processed meat with no impact on taste or nutrition values.
Join this webinar to learn about formulating alt meat applications with methylcellulose. Attendees will learn about enhancing the eating experience of alternative meat to increase consumer adoption.
Join experts from Ashland, Mary Jean Cash, Research Scientist, R&D, Food & Beverage, Life Sciences; Carmen Driskes, Senior Staff Scientist, R&D, Food & Beverage, Life Sciences; and Margie Best, Global Account Manager & North American Marketing Manager, Nutrition, Life Sciences, for the live webinar on Wednesday, September 20, 2023, at 10am EDT (4pm CEST/EU-Central).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2023 /PRNewswire/ — Harbour BioMed (“HBM”, or the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on…
Talking to your dentist about feeling fearful and anxious and the reasons for those feelings. Letting your dentist know that you’re anxious can help them tailor their approach to your needs. They may be able to offer you sedation options or take steps to make you more comfortable during your appointment.
Practicing relaxation techniques such as deep breathing or meditation can help patients feel more calm and centered before and during an appointment. Try to take a few minutes before the appointment to sit quietly and focus on breathing. Focusing on breathing during the procedure can also be calming.
Bring a trusted friend or family member to provide emotional support.
Distract yourself. Bring along a book, listen to music, or watch a movie during the appointment. Focusing on something other than fear and nervousness can contribute to a more relaxed appointment.
Use visualization, a powerful tool for helping overcome dental anxiety. Close your eyes and imagine being in a peaceful environment, such as a beach or a forest.
Consider sedation options, especially for severe anxiety. There are several options available, including nitrous oxide (also known as laughing gas), oral sedatives, and IV sedation. Talk to your dentist about which option is right for you.
Try desensitization therapy, which involves gradual exposure to the source of anxiety, in this case, the dentist’s office.
“Two very important tips are to practice good oral hygiene habits and to work with a dentist you trust,” says the Nipomo family dentist. Taking good care of your teeth and gums at home can reduce the amount of time needed in the dentist’s chair. Brush and floss regularly, and use an antibacterial mouthwash for a healthy mouth.
Finding a dentist you trust and feel comfortable with can make all the difference when it comes to overcoming dental anxiety. Dental anxiety can be a significant obstacle for many people, but it doesn’t have to prevent getting the necessary dental care. Being open about any anxiety with the dentist and the staff, means they are better able to help you overcome fears and nervousness.
At Nipomo Family Dentistry, personalized care starts the moment the patient walks through the doors. The entire staff offers honest, professional, and caring service and goes the extra mile to help fulfill all future dental goals.
The Nipomo dentist services range from routine cleanings, teeth whitening, and crowns, to complete dental care. Every patient, adults and kids alike, receives the finest and most up to date services available in dentistry. The staff takes pride in keeping up with the latest technologies, as well as the training required to use these new technologies correctly. This helps to ensure a smooth and pain free dental care experience.
Nipomo Family Dentistry 195 N Thompson Ave Suite #3 Nipomo, CA 93444 (805) 929-1888
“I look forward to lending my knowledge to the on-going success of Element Blue and its healthcare clients,” said Hanna. “The practice has strong leadership in Steven Gehardt and he’s built a great team. It will be a pleasure to contribute to the business’ growth and help develop creative solutions that produce tangible benefits for our customers.”
A true pioneer in the RPA industry, Hanna’s deep understanding of automation technology draws from a unique, 5-year opportunity to build an in-house robotic process automation (RPA) program for the world’s largest faith-based, not-for-profit healthcare system.
“After over 20 years in operations at Anthem/Wellpoint and the Ascension Ministry Service Center, having started one of the earliest dedicated RPA practices in the U.S. at Ascension nearly a decade ago and then supporting some of the largest providers and payers in the healthcare system as an advisor, I have a unique view on the challenges facing healthcare operations and the impact that intelligent automation tools can have,” said Hanna. “Along with the rest of the Element Blue team, I’ll be helping both existing and future clients focus on finding the right processes and using the right tools for the best outcome.”
About Element Blue
Element Blue (www.elementblue.com) enables healthcare systems to transform the patient experience and reduce costs through increased personalization and intelligent automation. The practice’s Blueprint Services Framework impacts referrals, patient access, the revenue cycle, and clinical encounters at the most critical stages of the customer journey, resulting in a seamless encounter across the system.
By empowering patients and employees to actively manage their unique healthcare experiences, Element Blue increases the satisfaction of every health system consumer: customers, patients and staff.
Söfft Shoe Company, makers of Nurse Mates, Söfft, Comfortiva, and EüroSoft, is excited to announce the official premiere of Align™, its newest men’s and women’s footwear brand, on AlignShoe.com.
ANDOVER, Mass., Aug. 25, 2023 /PRNewswire-PRWeb/ — Söfft Shoe Company, makers of Nurse Mates, Söfft, Comfortiva, and EüroSoft, is excited to announce the official premiere of Align™, its newest men’s and women’s footwear brand, on AlignShoe.com.
Specially designed to work with the foot’s natural contours, Align™ shoes feature an anatomical orthotic insole that places the foot in a more optimum position to assist with proper alignment, stability, and support. The unique design of this firm-yet-flexible footbed provides essential arch support and helps to reduce pressure on tendons, joints, and muscles of the feet, legs, and back.
Initially featured in select Nurse Mates styles, Align’s anatomical comfort technology is ideal for all ages and interests and for leisure, work, and fitness. In fact, the brand offers styles for everyday wear, healthcare and hospitality professionals, warehouse employees, and more.
“What began as a collection within our Nurse Mates line has grown exponentially in popularity, inspiring us to create Align™ as a stand-alone brand so everyone can experience its well-being benefits,” says Paul Sylvia, Align’s Vice President. “Wearing footwear that helps the body to work as intended is key for a healthier, more comfortable lifestyle, something everyone can enjoy.”
The AlignShoe.com debut collection includes five new men’s styles, four new women’s styles, and seven best-selling styles from the original Align™ Nurse Mates collection, including beloved customer favorites Torri and Velocity.
Other benefits of these lightweight, supportive shoes include a padded counter at the top of the heel to absorb impact, slip-resistant outsoles, stain-resistant uppers, and fluid-resistant toe shields in select styles. Customers can shop an exciting array of colors, from eye-catching metallic patterns and vibrant ombre designs to versatile classic neutrals.
To view the new Align™ collection and see the latest product updates, shop AlignShoe.com and visit Align Shoes on Facebook and @alignshoes on Instagram.
After turning to four health care providers near his hometown for answers on the best course of treatment, he was told that there were no options for his advanced reoccurring disease, which had spread to other parts of his body.
That’s when Martens discovered a Facebook support group for patients who have been diagnosed with pseudomyxoma peritonei – a rare type of cancer that typically forms via a cyst on the appendix – as well as related peritoneal surface malignancies.
That Facebook group soon led him to the Allegheny Health Network (AHN) Cancer Institute’s David Bartlett, MD, and Patrick Wagner, MD, both renowned surgeons specializing in surgery for this cancer and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Other patients in the worldwide group had shared their stories about successful surgery and HIPEC treatments by Drs. Bartlett and Wagner at AHN, and encouraged Martens to pursue the same. After receiving a second opinion from the clinicians at the AHN Cancer Institute, Martens traveled to Pittsburgh in early 2022 for his HIPEC procedure. However, there was a new investigational option to accompany his surgery – Martens was also a participant in OncoNano Medicine’s Phase 2 trial of pegsitacianine, a special chemical agent that “lights up” cancer cells by reacting with the cancer’s acidity.
HIPEC therapy involves bathing the patient’s abdominal cavity with a heated chemotherapy solution to kill off microscopic cancer cells, or small tumors that are tucked in the many folds and crevices of the abdominal cavity and can’t be reached by intravenous chemotherapy. The chemo solution is heated to between 107 and 109 degrees, hot enough to destroy cancer cells, but not healthy tissue.
Prior to the 90-minute HIPEC bath, though, the patient undergoes a cytoreduction, also known as a tumor debulking, of the abdominal cavity. That surgery involves the manual removal of all visible tumors – a surgery that can take five hours or more.
And that’s where the pegsitacianine comes in. A day or two before the surgical procedure, a patient is injected with pegsitacianine. After the abdominal debulking surgery begins, surgeons use an infrared camera to investigate and remove “glowing” cancer bits that otherwise would have been missed by the naked eye. Once the cytoreduction is complete, the HIPEC bath begins.
Dr. Wagner served as one of the investigators on the trial that uses pegsitacianine, which ultimately proved to be a game-changer for Martens’ procedure. This new investigational therapy gives surgeons the option to make highly invasive abdominal surgeries more effective and complete following a cancer diagnosis.
“Pegsitacianine can make cancerous tumors fluorescent under a certain light wavelength, which can be extremely beneficial to surgeons who may not be able to see every cancerous lesion using the naked eye during surgery,” said Dr. Wagner. “Early results of this clinical trial suggest that by combining pegsitacianine with surgery, we are better able to remove all of a patient’s existing cancer in one procedure, removing all cancer from the patient in one sweep.”
For Martens, the pegsitacianine agent allowed Dr. Wagner to remove cancerous areas in his rectum and bladder that they wouldn’t have caught otherwise.
“Mr. Martens’ case is highly encouraging, as are the other successes observed to date in this trial,” said Dr. Wagner. “We look forward to validating these findings in the upcoming Phase 3 trial.”
Pegsitacianine has been shown to “light up” tumors in all parts of the body, but Phase 2 of the study focused specifically on abdominal cancers and the agent’s utility during cytoreductive surgery. In study results presented during the American Society of Clinical Oncology’s annual meeting in early June, Dr. Wagner announced that in half of the patients who received the pegsitacianine, additional pathology-confirmed cancers were discovered through the camera investigation – tiny tumors that otherwise would not have been detected or removed during the typical standard of care surgery.
In other words, the fluorescent agent helped surgeons find more tumors than they normally would have, giving patients like Martens a better chance of a successful cytoreduction surgery and HIPEC procedure. And because the cancer cells are more readily visible, pegsitacianine has the potential to reduce the length of the surgery, which can involve hours of searching around the abdomen and between different organs.
It’s been over a year since Martens’ procedure at AHN. He’s back in Minnesota and he continues to complete follow-up telehealth visits with his doctors at AHN to monitor his progress. He currently has no evidence of disease within his body.
About the Allegheny Health Network – and the AHN Cancer Institute Allegheny Health Network is a western Pennsylvania-based integrated healthcare system that serves patients from across a five-state region that includes western Pennsylvania and the adjacent regions of Ohio, West Virginia, Maryland, and New York. The Network’s Cancer Institute employs more than 200 physicians and 500 oncology professionals who provide a complete spectrum of oncology care at 24 affiliated oncology clinics, including access to state-of-the-art technologies and new therapies being explored in hundreds of clinical cancer trials. The Cancer Institute has the only cancer program in the Pittsburgh region accredited as an Integrated Network Cancer Program by the American College of Surgeons Commission on Cancer, and its radiation oncology program is the largest in the country accredited by the American Society for Radiation Oncology. AHN Cancer Institute is a Quality Oncology Practice Initiative certified practice, and is accredited by the Foundation for Accreditation of Cellular Therapy, National Accreditation Program for Breast Centers and the National Accreditation Program for Rectal Cancer.
About OncoNano Medicine OncoNano Medicine is developing a new class of products that utilize principles of molecular cooperativity in their design to exploit pH as a biomarker to diagnose and treat cancer with high specificity. Our product candidates and interventions are designed to help patients across the continuum of cancer care and include solid tumor therapeutics, agents for real-time image guided surgery and a platform of immuno-oncology therapeutics that activate and guide the body’s immune system to target cancer. OncoNano’s lead development candidate is pegsitacianine, a novel fluorescent nanoprobe using the ON-BOARD platform, that is being studied as a real-time surgical imaging agent for use in multiple cancer surgeries and is advancing towards a pivotal clinical trial to aid in tumor detection of peritoneal carcinomatosis. ONM-501, OncoNano’s second development program, is a next generation STING (STimulator of INterferon Genes) agonist that is advancing towards a first in human trial in the first half of 2023. Pegsitacianine and ONM-501 have been supported by grants received from the Cancer Prevention Research Institute of Texas. Learn more at http://www.OncoNano.com.
SmART-Contour extends the capability of SmART-XPS preclinical treatment planning software available on the Small Animal Radiation Research Platform (SARRP). This powerful module for artificial intelligence-based contouring offers fast and accurate auto contouring for anatomical segmentation and plugs smoothly into SmART-XPS.
“Xstrahl is excited to extend our partnership with SmART Scientific Solutions and to be showcasing SmART-RAD and SmART-Contour at ICRR,” states Adrian Treverton, CEO of Xstrahl. “SmART-Contour really extends the functionality of SmART-XPS and the SARRP system, through both improving contouring accuracy and saving valuable time. SmART-RAD delivers accurate 3D dose planning software for any cabinet X-ray system. As more groups move from Cs-137 to X-ray irradiation, this is an essential tool to manage the significant change in radiation dose gradients and the 3D dose distributions that entails.”
Xstrahl is a medical technology company that designs radiation delivery devices to support clinical teams and cancer researchers. For more than 25 years, Xstrahl has been shaping the development of superficial and orthovoltage radiation therapy and advancing preclinical radiation research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.
About Smart Scientific Solutions
SmART Scientific Solutions B.V. was created in 2015 and is located in Maastricht (Netherlands).
Their mission is to develop products to support preclinical research involving imaging and irradiation of preclinical disease models. Their main products currently are radiation dose calculation tools for a variety of research platforms.
While curcumin and turmeric are amongst the most commonly used natural ingredients for joint health, the data on its effect on muscle health is conflicting. Additionally, the effective dose required to maintain the functionality of joints and muscles is equally important, as convenient daily dosing is shown to be associated with better compliance which provides consistent health benefits, resulting in higher consumer satisfaction.
This systematic review and meta-analysis of randomized clinical trials (RCTs) is intended to evaluate the effective dose, safety, and efficacy of commercial turmeric extract and curcumin supplements in musculoskeletal health. The research team performed a systematic literature search of PubMed, Google Scholar, and Cochrane Library databases and conducted a meta-analysis according to PRISMA guidelines. The research team analyzed 21 prospective, randomized clinical studies, of which seven studies were focused on skeletal muscle health and fourteen on joint health.
The studies concluded that turmeric extract and curcumin supplements can be effective adjuvants for the management of musculoskeletal health, with a low incidence of AEs. The water-dispersible turmeric extract, WDTE60N, at a dose of 250 mg per day, was found to be more effective than other curcumin products. The studies included in the analysis were conducted using diverse doses and treatment durations. Therefore, further evaluation using comparisons in future clinical trials can establish the appropriate, effective dose of curcumin supplements for the overall maintenance of musculoskeletal health.
“TurmXTRA continues to gain momentum with ongoing science and accolades in the industry,” says Rajat Mittal Shah, Co-founder and Executive Director of Nutriventia. “This meta-analysis shows overwhelming evidence of efficacy and safety for TurmXTRA and validates its benefits for the human musculoskeletal system against other market alternatives,” she adds. “TurmXTRA stands out from these products because of its optimized low dose formulation using natural source carriers and use of a simple and cost-effective solvent-free process.”
TurmXTRA has been awarded patents in the United States, the United Kingdom and India. These patents have been a priority in the innovation pipeline at Nutriventia and apply to the curcuminoid formulations exhibiting rapid dissolution and optimizing bioavailability from a low 250 mg once daily dose. TurmXTRA is also Clean Label Project certified, as it uses excipients obtained from natural sources and is derived from a solvent-free manufacturing process.
TurmXTRA has recently been lauded for its optimized bioavailability and clinical efficacy at a low 250mg dosage.
Nutriventia Limited, based in Mumbai, India, is a leader in combining the benefits and assurance of both science and nature in premium functional ingredients for health and wellness. Its inception can be traced to almost four decades ago, when two scientists with deep-rooted knowledge in medical sciences, ventured out to develop solutions that were an improvement on generic products becoming the pioneers of NDDS products in India. Through the use of proprietary and patented processes, Nutriventia has addressed issues and concerns in manufacturing, formulation, and clinical research, resulting in ingredients that are superior in quality and efficacy. Nutriventia’s dedication to innovation and improving ingredients is unparalleled, making them a preferred partner in the supplement industry. Their commitment to combining science and nature in the creation of high-quality, functional ingredients is a testament to their mission to improve health and wellness for consumers worldwide.
Mployer Advisor has named more than 500 winners in over 50 regions as part of its third annual 2023 awards. The class of 2023 winners account for less than 5% of all brokerages nationwide.
NASHVILLE, Tenn., Aug. 24, 2023 /PRNewswire-PRWeb/ — Mployer Advisor, the leading independent platform for employers to research, review, and evaluate insurance brokers has named over 500 winners across more than 50 regions as part of its third annual “Top Employee Benefits Consultant Awards” for 2023. Mployer Advisor’s Top Employee Benefits Consultant Award Program evaluates brokers based on breadth and depth of experience across employer industries, sizes, insurance products, and employer reviews. We recognize esteemed brokers that demonstrate market-leading competencies and a proven track record of success among employers, insurance providers, and peers.
Our team is proud to recognize this group of 2023 top-rated insurance advisors as part of our third annual Top Employee Benefits Consultant Awards,”‥said Brian Freeman, the Founder and CEO of Mployer Advisor. “Employer-sponsored healthcare and benefits cover over 150M Americans. Who an employer selects as their benefits advisor has more impact on employee cost and satisfaction with their healthcare than who an employer chooses as the insurance carrier. We have rated these brokerages utilizing sophisticated, industry-first algorithms, and we applaud the winners’ demonstrated commitment to service, quality, and positive employer feedback.”
Mployer Advisor determined the winners of the third annual “Top Employee Benefits Consultant Award” by analyzing each brokerage based on historical data, online reviews, their M Score rating, and demonstrated business experience.
The Detroit and Warren, Michigan job market is competitive in the U.S. Midwest, employing more than 2 million people. Offering competitive employee benefits is a critical factor in hiring top talent for the region’s employers. Finding and partnering with a highly rated insurance consultant is imperative to retaining talent in any market.
The recipients of the 2023 “Top Employee Benefits Consultant Awards” for Detroit and Warren, Michigan are as follows:
The above winners are a snapshot of Mployer Advisor’s matrices and proprietary M Score on June 15, 2023. To view a full list of consultants in Detroit and Warren, visit MployerAdvisor.com.
About Mployer Advisor:
Mployer Advisor is changing the way employers search, evaluate, and select insurance advisors. The intuitive platform connects employers and employees to great benefits and insurance plans by providing employers with actionable data to easily evaluate and select the best advisor for a company’s specific needs. Most brokerages have a profile on Mployer Advisor, which provides independent ratings of insurance advisors to support employers. Insurance brokers cannot pay to influence their Mployer Advisor rating. Only highly rated brokerages are allowed to advertise on the platform. To learn more about Mployer Advisor, visit https://mployeradvisor.com and follow us on LinkedIn.
Disclaimer: Rankings are dynamic, and this report may not reflect the rankings currently listed on Mployer Advisor’s website. Because Mployer Advisor’s research is ongoing, interested companies that want to join next year’s list are encouraged to claim their free profile on Mployer Advisor.
